| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relmada Therapeutics, Inc. (RLMD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. RLMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $9.52M | - | |
| COO | 828.0K | $6.06M | - | |
| Other | 828.0K | $6.06M | - | |
| CFO | 800.0K | $5.86M | - | |
| Dir | 164.0K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2021 | Traversa Sergio55 | CEO | Sale+OE | 3,278 | $35.07 | $114,969.62 | -1.8% | |
| Feb 3, 2021 | Shenouda Maged | CFO | Sale+OE | 3,200 | $35.04 | $112,133.92 | -41.3% | |
| Feb 2, 2021 | Kelly Paul Edward53 | Director | Sale+OE | 2,346 | $35.04 | $82,202.60 | -0.7% | |
| Feb 1, 2021 | Casamento Charles J71 | Director | Sell | 3,000 | $33.63 | $100,897.80 | -7.0% | |
| Jan 27, 2021 | Traversa Sergio55 | CEO | Sale+OE | 10,000 | $32.39 | $323,914.41 | -4.1% | |
| Jan 27, 2021 | Shenouda Maged | CFO | Sale+OE | 3,000 | $31.93 | $95,778.00 | -34.7% | |
| Jan 27, 2021 | Kelly Paul Edward53 | Director | Sale+OE | 5,000 | $32.46 | $162,322.88 | -1.1% | |
| Jan 26, 2021 | Kelly Paul Edward53 | Director | Sale+OE | 4,085 | $1,580.95 | $6,458,189.60 | -0.7% | |
| Jan 26, 2021 | Traversa Sergio55 | CEO | Sale+OE | 4,070 | $35.43 | $144,179.94 | -1.3% | |
| Jan 26, 2021 | Shenouda Maged | CFO | Sale+OE | 4,000 | $35.40 | $141,611.71 | -22.6% |